Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

SMAD4 is crucial for muscle repair in young adults but not in aged mice.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

The compound 4c showed strong potential as an anticancer agent.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

The new treatment was safe and may effectively treat male pattern hair loss.

Blocking mTORC1 reduces skin tumor growth in mice.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Mimicking the steroid A-ring may help create effective enzyme inhibitors for prostate disease treatment.

Smeathxanthone A improves wound healing and lowers blood sugar in diabetic mice.

AP-1 controls tumor cell type by affecting key signaling pathways.

New anti-acne medications are being tested to offer alternatives to current treatments.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

SM-215 promotes hair growth by improving the environment around hair follicles.

TGF-β2 helps activate hair follicle stem cells by counteracting BMP signals.

All-trans retinoic acid slows cell growth and increases cell death in goat hair follicles through a specific pathway.

Compound 4 is a promising treatment for hair loss with low toxicity.

A new topical treatment for hair loss shows promise by targeting androgen receptors.

Some blood pressure medications are linked to a higher risk of skin cancer.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Reduced alpha smooth muscle actin may cause hair loss in androgenetic alopecia.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.